what is the mechanism of action of glp-1 agonists Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms The activity of GLP-1 and

Namely: No longer covering GLP-1s for weight loss : Several insurers have made the choice to stop providing coverage for these drugs when used specifically for weight loss, while still covering them for other uses like diabetes

Therefore, it is necessary to consider the possibility that these changes affected the results

8.Nauck MA, Quast DR, Wefers J, Pfeiffer AFH

Notably, multiple clinical experiments show that systolic blood pressure (SBP) is decreased by GLP-1R agonists in T2DM hypertensive patients while DBP is less affected (92, 97, 98)

10.1007/s00125-011-2440-x

Glucagon-like peptide-1 (GLP-1), immediately prior to reperfusion, decreases neutrophil activation and reduces myocardial infarct size in rodents